+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Are all heart failure risk factors equal? Comparison of myocardial dysfunction late after chemotherapy with other stage a heart failure in community patients

Are all heart failure risk factors equal? Comparison of myocardial dysfunction late after chemotherapy with other stage a heart failure in community patients

Heart Lung & Circulation 24: S324-S325

(PDF emailed within 0-6 h: $19.90)

Accession: 064630346

Download citation: RISBibTeXText

DOI: 10.1016/j.hlc.2015.06.499

Related references

Risk factors and comorbidities in a community-wide sample of patients hospitalized with acute systolic or diastolic heart failure: the Worcester Heart Failure Study. Coronary Artery Disease 21(3): 137-143, 2010

Influence of Renal Sympathetic Denervation in Patients with Early-Stage Heart Failure Versus Late-Stage Heart Failure. International Heart Journal 59(1): 99-104, 2017

Current strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approach. Clinics 68(3): 401-409, 2014

High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs. Congestive Heart Failure 9(3): 127-132, 2003

Association of miR-197-5p, a Circulating Biomarker for Heart Failure, with Myocardial Fibrosis and Adverse Cardiovascular Events among Patients with Stage C or D Heart Failure. Cardiology 141(4): 212-225, 2019

Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort. Open Heart 5(2): E000782, 2018

Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after myocardial intarction in patients with left ventricular dysfunction, heart failure, or both. 2007

Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients). Circulation. Heart Failure 10(5), 2017

Prevention of heart failure by Ramipril in high risk patients without heart failure or systolic dysfunction. Journal of the American College of Cardiology 35(2 suppl A): 203A, 2000

Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance. Circulation. Heart Failure 10(12), 2017

Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry. Revista Espanola de Cardiologia 65(4): 326-333, 2012

Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registry. European Journal of Heart Failure 16(2): 173-179, 2014

Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. European Journal of Heart Failure 17(2): 169-176, 2015

Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. Journal of the American College of Cardiology 55(17): 1803-1810, 2010

Blunted cyclic variation of heart rate predicts mortality risk in post-myocardial infarction, end-stage renal disease, and chronic heart failure patients. Europace 19(8): 1392-1400, 2016